Market access hurdles are making the pursuit of outcomes needlessly difficult
This article was originally published in Clinica
Executive Summary
The implementation of creative solutions and breakthrough science in healthcare, rather than their discovery, is becoming the main concern of device and diagnostics companies. That is increasingly the consensus view.